drugset / Trial / NCT00002980

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

NCT00002980 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of decitabine in treating patients with stage III or stage IV melanoma or other advanced cancer that has not responded to previous therapy.

Timeline

Start
1997-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Decitabine Small molecule — —